Anaptysbio (ANAB) Property, Plant & Equipment (Net) Growth (1y) (2017 - 2026)
Powered by 
Analysis
Anaptysbio (ANAB) Property, Plant & Equipment (Net) Growth (1y) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.26 Bn | 131.41 Bn | 2.84 Bn | 24.71% |
| 2 | Regeneron Pharmaceuticals | 85.64 Bn | 77.64 Bn | 3.93 Bn | 12.77% |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | -99.85% |
| 4 | Moderna | 57.83 Bn | 52.69 Bn | 52.00 Mn | -5.07% |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | - |
| 6 | BeOne Medicines | 39.94 Bn | 34.84 Bn | 1.53 Bn | 1.70% |
| 7 | Alnylam Pharmaceuticals | 35.19 Bn | 31.88 Bn | 992.69 Mn | 10.87% |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.35 Bn | 26.19 Bn | 358.27 Mn | 19.14% |
| 10 | Anaptysbio | 1.62 Bn | 1.33 Bn | - | -26.48% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -26.48% |
| Dec 31, 2025 | -25.91% |
| Sep 30, 2025 | -13.19% |
| Jun 30, 2025 | -11.18% |
| Mar 31, 2025 | -10.90% |
| Dec 31, 2024 | -11.87% |
| Sep 30, 2024 | -23.34% |
| Jun 30, 2024 | -9.39% |
| Mar 31, 2024 | -1.41% |
| Dec 31, 2023 | 0.43% |
| Sep 30, 2023 | 14.30% |
| Jun 30, 2023 | -1.75% |
| Mar 31, 2023 | -8.33% |
| Dec 31, 2022 | -8.50% |
| Sep 30, 2022 | -18.28% |
| Jun 30, 2022 | -17.24% |
| Mar 31, 2022 | 23.26% |
| Dec 31, 2021 | 28.04% |
| Sep 30, 2021 | 52.24% |
| Jun 30, 2021 | 66.42% |